Genexine Inc. 13D and 13G filings for NovaBridge Biosciences:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-06-21 11:10 am Sale | 2021-05-19 | 13G | NOVABRIDGE BIOSCIENCES SPONSOR NBP | Genexine Inc. | 8,488,885 4.970% | -2,083,938 (-19.71%) | Filing |